Search

everythinglearnresearchcommunity

for

Search:↓

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

Swellable microneedles could improve drug delivery and diagnostics but need more research on materials and technology integration.

A parasite molecule can speed up skin healing and reduce scarring.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Different crystal forms of drugs can change their effectiveness.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Melanoma cells lose their ability to form tumors when placed in a zebrafish embryo environment.

Nanoparticle systems make cancer treatment less toxic.

Nanocarriers can improve skin treatments by effectively delivering drugs and enhancing skin hydration.

Niosomes are a promising method for delivering drugs directly to targeted areas in the body.

Imuvert can prevent some chemotherapy-induced hair loss.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Daprodustat, combined with PAβN, could be a new antibacterial treatment.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

Five FDA-approved drugs may help block COVID-19 virus entry.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

TGF-alpha is present in sheep and ferret skin and may affect hair growth without directly stimulating cell proliferation.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Neoplasms hide in hair follicles to avoid the immune system.

[6]-Gingerdiol 3-monoacetate shows promise for treating T. whipplei infections.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

A new delivery system makes Curcumin more effective and safer against viruses.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.